XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 1,288 $ 2,137
Short-term marketable securities 20 49
Accounts receivable, net of allowance of $4 and $5, respectively 949 853
Restricted cash and cash equivalents, current 134 137
Prepaid expenses and other current assets 118 129
Total current assets 2,509 3,305
Restricted cash and cash equivalents, noncurrent 19 19
Property and equipment, net 192 135
Operating lease right-of-use assets 23 31
Intangible assets, net 58 77
Goodwill 318 318
Deferred tax assets, net 775 830
Other assets 32 12
Total assets 3,926 4,727
Current liabilities:    
Accounts payable 69 72
Accrued and other current liabilities 530 451
Operating lease liabilities, current 12 13
Deferred revenue 209 197
Total current liabilities 820 733
Operating lease liabilities, noncurrent 16 27
Other long-term liabilities 34 40
Total liabilities 870 800
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value per share; 24,167 shares authorized as of December 31, 2023 and September 30, 2024; zero shares issued and outstanding as of December 31, 2023 and September 30, 2024 0 0
Common stock, $0.0001 par value per share; $2,000,000 shares authorized as of December 31, 2023 and September 30, 2024; 279,046, and $256,986 shares issued and outstanding as of December 31, 2023 and September 30, 2024, respectively 0 0
Additional paid-in capital 6,600 6,382
Accumulated other comprehensive income 0 3
Accumulated deficit (3,728) (2,635)
Total stockholders’ equity 2,872 3,750
Total liabilities, redeemable convertible preferred stock, and stockholders’ equity 3,926 4,727
Series A Redeemable Convertible Preferred Stock    
Current liabilities:    
Series A redeemable convertible preferred stock; $0.0001 par value per share; 5,833 shares authorized, issued, and outstanding as of December 31, 2023 and September 30, 2024 $ 184 $ 177